Drug Profile
Leukaemia DNA vaccine - Inovio/University of Southampton
Alternative Names: p.DOM-WT1-126; p.DOM-WT1-37Latest Information Update: 19 Sep 2018
Price :
$50
*
At a glance
- Originator University of Southampton
- Developer Inovio Pharmaceuticals; University of Southampton
- Class Cancer vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Acute myeloid leukaemia; Chronic myeloid leukaemia